These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2935417)

  • 1. Plasma lipoproteins can suppress accessory cell function and consequently suppress lymphocyte activation.
    Nakayasu T; Macy M; Okano Y; McCarthy BM; Harmony JA
    Exp Cell Res; 1986 Mar; 163(1):103-16. PubMed ID: 2935417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessory cells reduce lipoprotein suppression of lymphocyte activation.
    Okano Y; Macy M; Harmony JA
    Biochim Biophys Acta; 1985 Apr; 845(1):68-80. PubMed ID: 3872136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of lymphocyte activation by plasma lipoproteins: modulation by cell number and type.
    Okano Y; Macy M; Cardin AD; Harmony JA
    Exp Cell Biol; 1985; 53(4):199-212. PubMed ID: 3875509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.
    Cuthbert JA; Lipsky PE
    J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line.
    McCarthy BM; Okano Y; Nakayasu T; Macy M; Watson SR; Harmony JA
    J Lipid Res; 1987 Sep; 28(9):1067-77. PubMed ID: 3498779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lymphocyte activation by plasma lipoproteins.
    Macy M; Okano Y; Cardin AD; Avila EM; Harmony JA
    Cancer Res; 1983 May; 43(5 Suppl):2496s-2502s. PubMed ID: 6600967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation by low-density lipoproteins of the activation of oxidative enzyme-primed lymphocytes is governed by transferrin.
    Scupham DW; McCarthy BM; Harmony JA
    Cell Immunol; 1987 Sep; 108(2):378-95. PubMed ID: 3497727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of lipoproteins in suppression of interleukin 2-dependent cell proliferation by sera from aged humans.
    Ohtsuka Y; Kobayashi K; Hirano T; Furukawa S; Nagano S; Takahashi T
    Gerontology; 1990; 36(5-6):268-75. PubMed ID: 2150198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 response to arterial antigen, lipopolysaccharide, and oxidized low density lipoprotein in ischemic heart disease.
    Grasing K; Rifici V; Patel M; Patel A; Dennis R; Kostis JB
    J Investig Med; 1997 Oct; 45(8):474-82. PubMed ID: 9394101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro.
    Levy GA; Schwartz BS; Curtiss LK; Edgington TS
    J Clin Invest; 1981 Jun; 67(6):1614-22. PubMed ID: 7240410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane receptors for very low density lipoprotein (VLDL) inhibitor of lymphocyte proliferation.
    Yi PI; Beck G; Zucker S
    Blood; 1981 Jun; 57(6):1055-64. PubMed ID: 6261857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory cell paradox: monocytes enhance or inhibit lectin-mediated human T-lymphocyte proliferation depending on the choice of mitogen.
    Kilpatrick DC
    Scand J Immunol; 1988 Aug; 28(2):247-9. PubMed ID: 3261885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells.
    Avila EM; Holdsworth G; Sasaki N; Jackson RL; Harmony JA
    J Biol Chem; 1982 May; 257(10):5900-9. PubMed ID: 7068619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T-cell activation by oxidized low density lipoprotein.
    Frostegård J; Wu R; Giscombe R; Holm G; Lefvert AK; Nilsson J
    Arterioscler Thromb; 1992 Apr; 12(4):461-7. PubMed ID: 1558837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
    Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro.
    Ashida ER; Johnson AR; Lipsky PE
    J Clin Invest; 1981 May; 67(5):1490-9. PubMed ID: 6971878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat plasma lipoprotein inhibitors of lymphocyte proliferation: specific membrane receptor for very low density lipoproteins.
    Yi PI; Beck G; Zucker S
    Int Arch Allergy Appl Immunol; 1981; 65(1):8-14. PubMed ID: 7216515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct suppression of lymphocyte induction by the immunoregulatory human serum low density lipoprotein, LDL-In.
    Fujii DK; Edgington TS
    J Immunol; 1980 Jan; 124(1):156-60. PubMed ID: 6444224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of monocytes in the induction and regulation of IFN-gamma production by lectin-activated human T lymphocytes.
    Pryjma J; Ernst M; Fetting R; Woloszyn M; Zembala M; Flad HD
    Eur Cytokine Netw; 1991; 2(4):273-9. PubMed ID: 1756232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.